Overexpression of NF-κB/p65 protein was found in the nuclear fraction of prostate cancer clinical specimens [39], [40], suggesting the pathophysiological role for NF-κB in prostate cancer progression. This evidence concerns the gene NFKB1 and prostate carcinoma.